Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|January 31, 2004
Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabineHui Wang, Mao Li, John J Rinehart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapyHui Wang, Mao Li, John J Rinehart, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 27, 2012
Carboxylesterase-triggered hydrolysis of nanoparticle PEGylating agentsMelissa D Howard, Xiuling Lu, John J Rinehart, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 31, 2010
Physicochemical characterization of nanotemplate engineered solid lipid nanoparticlesMelissa D Howard, Xiuling Lu, John J Rinehart, et al.
International Journal of Oncology|March 3, 2007
Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokineticsHui Wang, Ying Wang, Elizabeth R Rayburn, et al.
The AAPS Journal|May 1, 2008
Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterizationXiuling Lu, Melissa D Howard, Marta Mazik, et al.
ACS Nano|December 17, 2010
Uniformity of drug payload and its effect on stability of solid lipid nanoparticles containing an ester prodrugJin-Ki Kim, Melissa D Howard, Thomas D Dziubla, et al.
The Prostate|July 15, 2005
Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancerPierre L Triozzi, Graeme B Bolger, Jeffrey Neidhart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignanciesSusanne M Arnold, John J Rinehart, Eleftheria Tsakalozou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancersPatricia M LoRusso, Smitha S Krishnamurthi, John J Rinehart, et al.
Pageof 1